Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion - PubMed (original) (raw)
. 2005 May 6;121(3):335-48.
doi: 10.1016/j.cell.2005.02.034.
Affiliations
- PMID: 15882617
- DOI: 10.1016/j.cell.2005.02.034
Free article
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
Akira Orimo et al. Cell. 2005.
Free article
Abstract
Fibroblasts often constitute the majority of the stromal cells within a breast carcinoma, yet the functional contributions of these cells to tumorigenesis are poorly understood. Using a coimplantation tumor xenograft model, we demonstrate that carcinoma-associated fibroblasts (CAFs) extracted from human breast carcinomas promote the growth of admixed breast carcinoma cells significantly more than do normal mammary fibroblasts derived from the same patients. The CAFs, which exhibit the traits of myofibroblasts, play a central role in promoting the growth of tumor cells through their ability to secrete stromal cell-derived factor 1 (SDF-1); CAFs promote angiogenesis by recruiting endothelial progenitor cells (EPCs) into carcinomas, an effect mediated in part by SDF-1. CAF-secreted SDF-1 also stimulates tumor growth directly, acting through the cognate receptor, CXCR4, which is expressed by carcinoma cells. Our findings indicate that fibroblasts within invasive breast carcinomas contribute to tumor promotion in large part through the secretion of SDF-1.
Similar articles
- Stromal fibroblasts in cancer: a novel tumor-promoting cell type.
Orimo A, Weinberg RA. Orimo A, et al. Cell Cycle. 2006 Aug;5(15):1597-601. doi: 10.4161/cc.5.15.3112. Epub 2006 Aug 1. Cell Cycle. 2006. PMID: 16880743 Review. - Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
Huang M, Li Y, Zhang H, Nan F. Huang M, et al. J Exp Clin Cancer Res. 2010 Jun 22;29(1):80. doi: 10.1186/1756-9966-29-80. J Exp Clin Cancer Res. 2010. PMID: 20569497 Free PMC article. - Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F, Tian WY, Wang YM, Zhang YF, Guo F, Zhao J, Gao C, Xue FX. Teng F, et al. J Hematol Oncol. 2016 Feb 6;9:8. doi: 10.1186/s13045-015-0231-4. J Hematol Oncol. 2016. PMID: 26851944 Free PMC article. - Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, Onder TT, Wang ZC, Richardson AL, Weinberg RA, Orimo A. Kojima Y, et al. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14. doi: 10.1073/pnas.1013805107. Epub 2010 Nov 1. Proc Natl Acad Sci U S A. 2010. PMID: 21041659 Free PMC article. - CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
Burger JA, Kipps TJ. Burger JA, et al. Blood. 2006 Mar 1;107(5):1761-7. doi: 10.1182/blood-2005-08-3182. Epub 2005 Nov 3. Blood. 2006. PMID: 16269611 Review.
Cited by
- Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling.
Wang Y, Lan W, Xu M, Song J, Mao J, Li C, Du X, Jiang Y, Li E, Zhang R, Wang Q. Wang Y, et al. Cell Death Dis. 2021 Feb 26;12(2):214. doi: 10.1038/s41419-021-03509-x. Cell Death Dis. 2021. PMID: 33637678 Free PMC article. - Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.
Polo ML, Riggio M, May M, Rodríguez MJ, Perrone MC, Stallings-Mann M, Kaen D, Frost M, Goetz M, Boughey J, Lanari C, Radisky D, Novaro V. Polo ML, et al. Oncotarget. 2015 Sep 8;6(26):22081-97. doi: 10.18632/oncotarget.4203. Oncotarget. 2015. PMID: 26098779 Free PMC article. - Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.
Li P, Shan JX, Chen XH, Zhang D, Su LP, Huang XY, Yu BQ, Zhi QM, Li CL, Wang YQ, Tomei S, Cai Q, Ji J, Li JF, Chouchane L, Yu YY, Sun FZ, Xu ZH, Liu BY, Zhu ZG. Li P, et al. Cell Res. 2015 May;25(5):588-603. doi: 10.1038/cr.2015.51. Epub 2015 Apr 28. Cell Res. 2015. PMID: 25916550 Free PMC article. - Blood vessels as targets in tumor therapy.
Claesson-Welsh L. Claesson-Welsh L. Ups J Med Sci. 2012 May;117(2):178-86. doi: 10.3109/03009734.2012.660550. Epub 2012 Feb 21. Ups J Med Sci. 2012. PMID: 22348394 Free PMC article. Review. - Biological and mutational analyses of CXCR4-antagonist interactions and design of new antagonistic analogs.
Meng Q, Zhu R, Mao Y, Zhu S, Wu Y, Huang LSM, Ciechanover A, An J, Xu Y, Huang Z. Meng Q, et al. Biosci Rep. 2023 Dec 22;43(12):BSR20230981. doi: 10.1042/BSR20230981. Biosci Rep. 2023. PMID: 38131305 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials